Intratumoral HLA-DR(−)/CD33(+)/CD11b(+) Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Capecitabine-based neoadjuvant chemoradiation therapy (nCRT) is currently the mainstay of treatment for locally advanced rectal cancer (LARC), prior to surgical tumor removal. While response to this treatment is partial, it carries significant risk of side effects. As of today, there is no accepted...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Oncol
Auteurs principaux: Hasnis, Erez, Dahan, Aviva, Khoury, Wissam, Duek, Daniel, Fisher, Yael, Beny, Alex, Shaked, Yuval, Chowers, Yehuda, Half, Elizabeth E.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2020
Sujets:
Oncology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7435035/
https://ncbi.nlm.nih.gov/pubmed/32903466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01375
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires